Manchanda R K, Miglani A, Chakraborty M, Kalsi A, Meena B S, Kaur P, Saini B, Arora A, Nagrath C, Thavarayil Kannoth J, Kudiyarasu R K, Vardaan R, Brahmachari S, Kumar Y, Amitav B, Konthembath P, Gupta A, Lolugu S K, Goel P, Arora S, et al.
The clinical profile and course of COVID-19 evolved perilously in a second wave, leading to the use of various treatment modalities that included homeopathy. This prognostic factor research (PFR) study aimed to identify clinically useful homeopathic medicines in this second wave.
This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the IASP Privacy Policy. By closing this banner, you agree to the use of cookies.Agree
